NATURE’S SUNSHINE PRODUCTS, INC. Impairment of Long-Lived Assets Held-for-use
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Impairment of Long-Lived Assets Held-for-use of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfLongLivedAssetsHeldForUse · last filed 2019-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for the quarter ending 2018-06-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for the quarter ending 2017-09-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for the quarter ending 2017-06-30 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for the quarter ending 2014-12-31 was $0.00.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for fiscal 2017 was $113.00K, a 48.87% decline from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for fiscal 2016 was $221.00K.
- NATURE’S SUNSHINE PRODUCTS, INC. impairment of long-lived assets held-for-use for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
| Period end | Impairment of Long-Lived Assets Held-for-use 3 month | Impairment of Long-Lived Assets Held-for-use 6 month | Impairment of Long-Lived Assets Held-for-use 9 month | Impairment of Long-Lived Assets Held-for-use 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 10-K · filed 2019-03-08 | |||
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||
| 2017-12-31 | $113.00K 10-K · filed 2019-03-08 | |||
| 2017-09-30 | $0.00 10-Q · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2018-08-08 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-08 | $0.00 10-Q · filed 2018-08-08 | ||
| 2016-12-31 | $221.00K 10-K · filed 2019-03-08 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-16 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $2.95M 10-K · filed 2017-03-14 | ||
| 2014-09-30 | $2.95M 10-Q · filed 2015-11-06 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |